{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:39:05Z","timestamp":1792741145071,"version":"4.5.0"},"reference-count":37,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T00:00:00Z","timestamp":1791676800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T00:00:00Z","timestamp":1791676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Public Health Rep"],"abstract":"<jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>Understanding pneumococcal vaccine uptake across county-level social vulnerability is important for identifying geographic disparities and informing strategies to increase vaccine uptake and reduce the incidence of pneumococcal disease (PD). Using a retrospective cohort design, we characterized differences in vaccine uptake among publicly insured US adults, comparing vaccination rates among beneficiaries in counties with high versus low social vulnerability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We assessed uptake and disease risk using claims for Medicare (aged \u226565 y; 2016-2019) and Medicaid (low income or disabled; 2017-2019) beneficiaries. We measured county-level social vulnerability using the 2021 Minority Health Social Vulnerability Index (overall score and 6 theme scores).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Of the 56.9 million Medicare beneficiaries analyzed, 36.9% received a pneumococcal vaccine, as did 7.6% of the 8.6 million Medicaid beneficiaries. Vaccine uptake was significantly lower in counties with the highest versus lowest social vulnerability (34.8% vs 38.6% among Medicare beneficiaries,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&lt;\u2009.001 and 7.3% vs 7.9% among Medicaid beneficiaries,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&lt;\u2009.001). Disparities were most pronounced when vulnerability was based on the socioeconomic status theme in the Medicare cohort and on the health care infrastructure and access theme in the Medicaid cohort. The overall pattern was reversed (with higher uptake in the most vulnerable counties) when vulnerability was based on the minority status and language theme among Medicaid beneficiaries at high risk for PD. Controlling for beneficiary characteristics (age group, sex, disease risk status, race and ethnicity, and urbanicity) strengthened the association between vulnerability and uptake.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>These findings suggest that county- and individual-level factors are associated with disparities in pneumococcal vaccine uptake and underscore the need for tailored clinical, community, and policy strategies to boost pneumococcal vaccine uptake in socially vulnerable populations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/00333549261488379","type":"journal-article","created":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T03:30:55Z","timestamp":1791775855000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Area-Level Disparities in Pneumococcal Vaccination Among Publicly Insured US Adults: 2016-2019"],"prefix":"10.1177","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7610-6467","authenticated-orcid":false,"given":"Salini","family":"Mohanty","sequence":"first","affiliation":[{"name":"Merck &amp; Co, Inc, Rahway, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7113-0561","authenticated-orcid":false,"given":"Saumya","family":"Chatrath","sequence":"additional","affiliation":[{"name":"Mathematica, Inc, Princeton, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Shanmugam","sequence":"additional","affiliation":[{"name":"Mathematica, Inc, Princeton, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Cossrow","sequence":"additional","affiliation":[{"name":"Merck &amp; Co, Inc, Rahway, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Fiduccia","sequence":"additional","affiliation":[{"name":"Merck &amp; Co, Inc, Rahway, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelsie","family":"Cassell","sequence":"additional","affiliation":[{"name":"Merck &amp; Co, Inc, Rahway, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Smith-Howell","sequence":"additional","affiliation":[{"name":"Merck &amp; Co, Inc, Rahway, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valina C.","family":"McGuinn","sequence":"additional","affiliation":[{"name":"Merck &amp; Co, Inc, Rahway, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelena","family":"Zurovac","sequence":"additional","affiliation":[{"name":"Mathematica, Inc, Princeton, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constance","family":"Delannoy","sequence":"additional","affiliation":[{"name":"Mathematica, Inc, Princeton, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa","family":"Evans","sequence":"additional","affiliation":[{"name":"Mathematica, Inc, Princeton, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Barna","sequence":"additional","affiliation":[{"name":"Mathematica, Inc, Princeton, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aparna","family":"Keshaviah","sequence":"additional","affiliation":[{"name":"Mathematica, Inc, Princeton, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen A.","family":"Feemster","sequence":"additional","affiliation":[{"name":"Merck &amp; Co, Inc, Rahway, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,10,11]]},"reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.05.030"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.02.088"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.15620\/cdc:82532"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a010215"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad192"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000000025"},{"key":"e_1_3_5_8_2","unstructured":"Centers for Disease Control and Prevention. Pneumococcal Vaccine Recommendations. Centers for Disease Control and Prevention; 2026. Accessed August 3 2026. https:\/\/www.cdc.gov\/pneumococcal\/hcp\/vaccine-recommendations\/index.html"},{"key":"e_1_3_5_9_2","unstructured":"Centers for Disease Control and Prevention. CDC recommends lowering the age for pneumococcal vaccination from 65 to 50 years old. News release. October 23 2024. Accessed December 2 2024. https:\/\/www.cdc.gov\/media\/releases\/2024\/s1023-pneumococcal-vaccination.html"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201511-778FR"},{"key":"e_1_3_5_11_2","unstructured":"Kobayashi M. Summary of work group interpretations of EtR and policy option on PCV21 use in adults. ACIP Meeting Presentation. 2024. Accessed August 3 2026. https:\/\/stacks.cdc.gov\/view\/cdc\/157880"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa515"},{"key":"e_1_3_5_13_2","unstructured":"Centers for Disease Control and Prevention. Vaccination Coverage Among Adults in the United States National Health Interview Survey 2021. Centers for Disease Control and Prevention; 2024. Accessed August 8 2024. https:\/\/www.cdc.gov\/adultvaxview\/publications-resources\/vaccination-coverage-adults-2021.html"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2018.1564434"},{"key":"e_1_3_5_15_2","unstructured":"National Center for Immunization and Respiratory Diseases Centers for Disease Control and Prevention. COVID-19 Vaccine Uptake and CDC\u2019s Commitment to Vaccine Equity. National Center for Immunization and Respiratory Diseases Centers for Disease Control and Prevention; 2023. Accessed August 13 2024. https:\/\/www.cdc.gov\/ncird\/whats-new\/vaccine-equity.html"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2022.2055422"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2023.02.022"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2022.4814"},{"key":"e_1_3_5_19_2","unstructured":"Centers for Medicare & Medicaid Services. Data Quality Atlas. 2024. Accessed July 28 2024. https:\/\/www.medicaid.gov\/dq-atlas\/welcome"},{"key":"e_1_3_5_20_2","unstructured":"Office of Minority Health US Department of Health and Human Services. Minority Health Index. 2025. Accessed August 3 2026. https:\/\/minorityhealth.hhs.gov\/minority-health-svi"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/1540-6237.8402002"},{"issue":"10","key":"e_1_3_5_22_2","first-page":"34","article-title":"Measuring community vulnerability to natural and anthropogenic hazards: the Centers for Disease Control and Prevention\u2019s Social Vulnerability Index","volume":"80","author":"Flanagan BE","year":"2018","unstructured":"Flanagan BE, Hallisey EJ, Adams E, Lavery A. Measuring community vulnerability to natural and anthropogenic hazards: the Centers for Disease Control and Prevention\u2019s Social Vulnerability Index. J Environ Health. 2018;80(10):34-36.","journal-title":"J Environ Health"},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.1037\/0003-066X.32.7.513"},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.1177\/109019818801500401"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.2307\/2626958"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.1177\/0022146510383498"},{"key":"e_1_3_5_27_2","unstructured":"Economic Research Service US Department of Agriculture. Rural\u2013urban continuum codes. 2025. Accessed August 3 2026. https:\/\/www.ers.usda.gov\/data-products\/rural-urban-continuum-codes"},{"key":"e_1_3_5_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2024.01.049"},{"key":"e_1_3_5_29_2","unstructured":"Centers for Medicare & Medicaid Services Office of Minority Health. Data Snapshot: Annual Influenza Vaccination Disparities in Medicare Beneficiaries. Centers for Medicare & Medicaid Services Office of Minority Health; 2024. Accessed August 3 2026. https:\/\/www.cms.gov\/files\/document\/data-snapshot-annual-influenza-vaccination.pdf"},{"key":"e_1_3_5_30_2","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11111712"},{"key":"e_1_3_5_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.06.077"},{"key":"e_1_3_5_32_2","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2020.617976"},{"key":"e_1_3_5_33_2","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2019.1688033"},{"key":"e_1_3_5_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.02.061"},{"key":"e_1_3_5_35_2","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2023.2226718"},{"key":"e_1_3_5_36_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-018-4471-1"},{"key":"e_1_3_5_37_2","doi-asserted-by":"publisher","DOI":"10.1177\/0046958019838118"},{"key":"e_1_3_5_38_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.3316"}],"container-title":["Public Health Reports\u00ae"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/00333549261488379","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/00333549261488379","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/00333549261488379","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:04:49Z","timestamp":1792739089000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/00333549261488379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,11]]},"references-count":37,"alternative-id":["10.1177\/00333549261488379"],"URL":"https:\/\/doi.org\/10.1177\/00333549261488379","relation":{},"ISSN":["0033-3549","1468-2877"],"issn-type":[{"value":"0033-3549","type":"print"},{"value":"1468-2877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,11]]},"article-number":"00333549261488379"}}